l-Dopa and Dopamine-Producing Gene Cassettes for Gene Therapy Approaches to Parkinson's Disease

By Moffat M.   Harmon S.   Haycock J.   O'Malley K.L.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

Long-term l-DOPA therapy: challenges to our understanding and for the care of people with Parkinson's disease

By Nutt J.G.  

Experimental Neurology, Vol. 184, Iss. 1, 2003-11 ,pp. : 9-13

Elsevier

Access to resources Recommend Favorite

Progress in Direct Striatal Delivery of l-Dopa via Gene Therapy for Treatment of Parkinson's Disease Using Recombinant Adeno-Associated Viral Vectors

By Mandel R.J.   Rendahl K.G.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 47-64

Elsevier

Access to resources Recommend Favorite

Influence of chronic administration of l-DOPA on event-related desynchronization of mu rhythm preceding voluntary movement in Parkinson's disease

By Defebvre L.   Bourriez J.L.   Derambure P.   Duhamel A.   Guieu J.D.   Destee A.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 109, Iss. 2, 1998-04 ,pp. : 161-167

Elsevier

Access to resources Recommend Favorite

Effect of Acute l-Dopa Pretreatment on Apomorphine-Induced Rotational Behavior in a Rat Model of Parkinson's Disease

By Mandel R.J.  

Experimental Neurology, Vol. 161, Iss. 1, 2000-01 ,pp. : 212-219

Elsevier

Access to resources Recommend Favorite